These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 10513271

  • 1. Unconventional therapies and cancer.
    Bégin M, Kaegi E.
    CMAJ; 1999 Sep 21; 161(6):686-7. PubMed ID: 10513271
    [No Abstract] [Full Text] [Related]

  • 2. Reactive oxygen species may have antitumor activity in metastatic melanoma.
    Tuma RS.
    J Natl Cancer Inst; 2008 Jan 02; 100(1):11-2. PubMed ID: 18159075
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E.
    CMAJ; 1998 May 19; 158(10):1327-30. PubMed ID: 9614826
    [No Abstract] [Full Text] [Related]

  • 7. Molecule of the month. Elesclomol and obatoclax mesylate.
    Drug News Perspect; 2008 Mar 19; 21(2):123-4. PubMed ID: 18389103
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin C as a cancer treatment: state of the science and recommendations for research.
    Tamayo C, Richardson MA.
    Altern Ther Health Med; 2003 Mar 19; 9(3):94-101. PubMed ID: 12776480
    [No Abstract] [Full Text] [Related]

  • 9. Are targeted therapies really targeted?
    Schilsky RL.
    Clin Adv Hematol Oncol; 2003 Dec 19; 1(12):722-3. PubMed ID: 16258475
    [No Abstract] [Full Text] [Related]

  • 10. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ, Dueck A, Sargent DJ.
    Cancer Invest; 2008 Jun 19; 26(5):439-44. PubMed ID: 18568764
    [No Abstract] [Full Text] [Related]

  • 11. Improving the design of phase II trials of cytostatic anticancer agents.
    Stone A, Wheeler C, Barge A.
    Contemp Clin Trials; 2007 Feb 19; 28(2):138-45. PubMed ID: 16843736
    [Abstract] [Full Text] [Related]

  • 12. Newer phase II trial designs gaining ground.
    Benowitz S.
    J Natl Cancer Inst; 2007 Oct 03; 99(19):1428-9. PubMed ID: 17895467
    [No Abstract] [Full Text] [Related]

  • 13. Multi-arm clinical trials of new agents: some design considerations.
    Freidlin B, Korn EL, Gray R, Martin A.
    Clin Cancer Res; 2008 Jul 15; 14(14):4368-71. PubMed ID: 18628449
    [Abstract] [Full Text] [Related]

  • 14. The Di Bella multitherapy trial. Criticism ignores standard methodology of cancer treatments.
    Raschetti R, Greco D, Menniti-Ippolito F, Spila-Alegiani S, Benagiano G, Bruzzi P.
    BMJ; 1999 Apr 17; 318(7190):1074. PubMed ID: 10336293
    [No Abstract] [Full Text] [Related]

  • 15. Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology.
    Efficace F, Horneber M, Lejeune S, Van Dam F, Leering S, Rottmann M, Aaronson NK.
    J Clin Epidemiol; 2006 Dec 17; 59(12):1257-65. PubMed ID: 17098568
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled trials as evidence in legal disputes about the benefits of complementary and alternative medicine.
    Coulter ID, Walsh J.
    Altern Ther Health Med; 2008 Dec 17; 14(2):60-4. PubMed ID: 18383991
    [No Abstract] [Full Text] [Related]

  • 17. Criticism of tumor response criteria raises trial design questions.
    Twombly R.
    J Natl Cancer Inst; 2006 Feb 15; 98(4):232-4. PubMed ID: 16478740
    [No Abstract] [Full Text] [Related]

  • 18. Complementary and alternative therapies: the power of randomization.
    Wild R.
    J Soc Gynecol Investig; 2006 Jan 15; 13(1):1. PubMed ID: 16378909
    [No Abstract] [Full Text] [Related]

  • 19. The roles of complementary medicine in oncology.
    Lamson DW.
    Altern Med Rev; 2007 Dec 15; 12(4):313-8. PubMed ID: 18069900
    [No Abstract] [Full Text] [Related]

  • 20. Phase II trials in journal of clinical oncology.
    Cannistra SA.
    J Clin Oncol; 2009 Jul 01; 27(19):3073-6. PubMed ID: 19451415
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.